Industry Pharmacogenomics Working Group Inc
| Fiscal year | Revenue | Expenses | Net | Reserve mo. | Staff % |
|---|---|---|---|---|---|
| 2018 | 136,000 | 9,036 | 126,964 | 168.6 | — |
| 2019 | 103,985 | 61,576 | 42,409 | 33.0 | — |
| 2020 | 119,919 | 54,323 | 65,596 | 51.9 | — |
| 2021 | 116,985 | 86,043 | 30,942 | 37.1 | — |
| 2022 | 79,952 | 114,989 | −35,037 | 24.1 | — |
| 2023 | 120,092 | 88,934 | 31,158 | 35.4 | — |
In its most recent public year (2023), this organization brought in $31,158 more than it spent. Its reserves stood at about 35.4 months of spending, down from 168.6 in 2018.
Reserve months = net assets ÷ average monthly spending; net assets count everything the organization owns beyond its debts — buildings and donor-restricted funds included, not just cash. Staff pay = salaries, wages, and officer compensation; it excludes benefits and payroll taxes. The IRS releases this data years after the fact — this organization's newest public year is 2023. Years refer to the calendar year in which the organization's fiscal year ended. Short-form filers do not publicly report donor-restricted balances or staffing costs. Source filings
Industry Pharmacogenomics Working Group Inc's IRS filings as a feed — one entry per filing year, through 2023. Add the address to any feed reader; in Slack, send /feed subscribe with it (pasting the link alone won't subscribe). How this feed works